StockData
Anterix Inc. logo

Anterix Inc. (ATEX) stock

ATEXNasdaqTelephone Communications (No Radiotelephone)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3074% above fair value
$78.86+2.12 (+2.76%)

Close on Nov 17, 2026Market cap $1.55BP/E 22.5Yield –

Anterix r&d expenses

Research and development expenses are spending on new products and technology.

Anterix's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.80M, down 5.9% year over year. For fiscal 2026 it was $4.70M, down 18.0% from the year before. Over ten years it grew 13.5% a year on average. The highest annual figure on record is $5.74M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$4.70M-18.0%
FY2025Mar 31, 2025$5.74M+0.7%
FY2024Mar 31, 2024$5.70M+28.3%
FY2023Mar 31, 2023$4.44M+23.5%
FY2022Mar 31, 2022$3.59M-17.3%
FY2021Mar 31, 2021$4.34M+47.1%
FY2020Mar 31, 2020$2.95M+29.2%
FY2019Mar 31, 2019$2.29M-2.8%
FY2018Mar 31, 2018$2.35M+1.6%
FY2017Mar 31, 2017$2.32M+75.1%
FY2016Mar 31, 2016$1.32M+32.2%
FY2015Mar 31, 2015$1.00M+7.1%
FY2014Mar 31, 2014$934.82K+30.6%
FY2013Mar 31, 2013$715.92K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$1.22M+8.9%
Q4 FY2026CQ1 2026Mar 31, 2026$1.27M+16.3%
Q3 FY2026CQ4 2025Dec 31, 2025$1.10M-1.4%
Q2 FY2026CQ3 2025Sep 30, 2025$1.21M-31.8%
Q1 FY2026CQ2 2025Jun 30, 2025$1.12M-36.0%
Q4 FY2025CQ1 2025Mar 31, 2025$1.09M-51.4%
Q3 FY2025CQ4 2024Dec 31, 2024$1.12M-9.5%
Q2 FY2025CQ3 2024Sep 30, 2024$1.78M+54.8%
Q1 FY2025CQ2 2024Jun 30, 2024$1.75M+63.7%
Q4 FY2024CQ1 2024Mar 31, 2024$2.24M+57.2%
Q3 FY2024CQ4 2023Dec 31, 2023$1.24M+32.3%
Q2 FY2024CQ3 2023Sep 30, 2023$1.15M+17.0%
Q1 FY2024CQ2 2023Jun 30, 2023$1.07M-2.5%
Q4 FY2023CQ1 2023Mar 31, 2023$1.43M+86.0%
Q3 FY2023CQ4 2022Dec 31, 2022$936.00K+4.8%
Q2 FY2023CQ3 2022Sep 30, 2022$980.00K+5.4%
Q1 FY2023CQ2 2022Jun 30, 2022$1.10M+9.3%
Q4 FY2022CQ1 2022Mar 31, 2022$767.00K-41.5%
Q3 FY2022CQ4 2021Dec 31, 2021$893.00K-28.2%
Q2 FY2022CQ3 2021Sep 30, 2021$930.00K-5.9%
Q1 FY2022CQ2 2021Jun 30, 2021$1.00M+25.2%
Q4 FY2021CQ1 2021Mar 31, 2021$1.31M+18.3%
Q3 FY2021CQ4 2020Dec 31, 2020$1.24M+103.9%
Q2 FY2021CQ3 2020Sep 30, 2020$988.00K+78.0%
Q1 FY2021CQ2 2020Jun 30, 2020$801.00K+17.8%
Q4 FY2020CQ1 2020Mar 31, 2020$1.11M+151.6%
Q3 FY2020CQ4 2019Dec 31, 2019$610.00K-5.7%
Q2 FY2020CQ3 2019Sep 30, 2019$555.00K-2.3%
Q1 FY2020CQ2 2019Jun 30, 2019$680.00K+6.8%
Q4 FY2019CQ1 2019Mar 31, 2019$440.00K-24.1%
Q3 FY2019CQ4 2018Dec 31, 2018$647.00K+9.3%
Q2 FY2019CQ3 2018Sep 30, 2018$568.00K-9.6%
Q1 FY2019CQ2 2018Jun 30, 2018$637.00K+15.4%
Q4 FY2018CQ1 2018Mar 31, 2018$580.00K-0.3%
Q3 FY2018CQ4 2017Dec 31, 2017$592.00K+9.8%
Q2 FY2018CQ3 2017Sep 30, 2017$628.00K+1.0%
Q1 FY2018CQ2 2017Jun 30, 2017$552.00K–
Q4 FY2017CQ1 2017Mar 31, 2017$582.00K–
Q3 FY2017CQ4 2016Dec 31, 2016$539.00K–
Q2 FY2017CQ3 2016Sep 30, 2016$622.00K–

More Anterix figures

See a number that looks wrong?